Compounds > n-(n-benzylpiperidin-4-yl)-4-iodobenzamide
Page last updated: 2024-09-04

n-(n-benzylpiperidin-4-yl)-4-iodobenzamide and 1,3-ditolylguanidine

n-(n-benzylpiperidin-4-yl)-4-iodobenzamide has been researched along with 1,3-ditolylguanidine in 1 studies

Compound Research Comparison

Studies
(n-(n-benzylpiperidin-4-yl)-4-iodobenzamide)		Trials
(n-(n-benzylpiperidin-4-yl)-4-iodobenzamide)		Recent Studies (post-2010)
(n-(n-benzylpiperidin-4-yl)-4-iodobenzamide)		Studies
(1,3-ditolylguanidine)		Trials
(1,3-ditolylguanidine)		Recent Studies (post-2010) (1,3-ditolylguanidine)
1103357071

Protein Interaction Comparison

ProteinTaxonomyn-(n-benzylpiperidin-4-yl)-4-iodobenzamide (IC50)1,3-ditolylguanidine (IC50)
polyadenylate-binding protein 1Homo sapiens (human)19.8
RevHuman immunodeficiency virus 18.312
Female germline-specific tumor suppressor gld-1Caenorhabditis elegans5.205
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.036
Sigma non-opioid intracellular receptor 1Rattus norvegicus (Norway rat)0.1816

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bowen, WD; John, CS; Vilner, BJ1

Other Studies

1 other study(ies) available for n-(n-benzylpiperidin-4-yl)-4-iodobenzamide and 1,3-ditolylguanidine

ArticleYear
Synthesis and characterization of [125I]-N-(N-benzylpiperidin-4-yl)-4- iodobenzamide, a new sigma receptor radiopharmaceutical: high-affinity binding to MCF-7 breast tumor cells.
    Journal of medicinal chemistry, 1994, Jun-10, Volume: 37, Issue:12

    Topics: Animals; Benzamides; Binding Sites; Breast Neoplasms; Guinea Pigs; Humans; Iodine Radioisotopes; Piperidines; Radionuclide Imaging; Receptors, sigma; Tumor Cells, Cultured

1994